These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 29924357)

  • 21. Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
    Bellanger AP; Albert ND; Lewis RE; Walsh TJ; Kontoyiannis DP
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7830-2. PubMed ID: 26392499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
    Chowdhary A; Singh PK; Kathuria S; Hagen F; Meis JF
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7882-7. PubMed ID: 26438489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
    Salas V; Pastor FJ; Calvo E; Alvarez E; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
    Antimicrob Agents Chemother; 2012 May; 56(5):2246-50. PubMed ID: 22290952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
    Rybak JM; Marx KR; Nishimoto AT; Rogers PD
    Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
    Schwarz P; Schwarz PV; Felske-Zech H; Dannaoui E
    J Antimicrob Chemother; 2019 Jul; 74(7):1921-1927. PubMed ID: 30934052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
    Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
    BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
    Miceli MH; Kauffman CA
    Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the efficacy of antifungal drugs against Paracoccidioides brasiliensis and Paracoccidioides lutzii in a Galleria mellonella model.
    de Lacorte Singulani J; Scorzoni L; de Paula E Silva AC; Fusco-Almeida AM; Mendes-Giannini MJ
    Int J Antimicrob Agents; 2016 Sep; 48(3):292-7. PubMed ID: 27444116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.
    Ervens J; Ghannoum M; Graf B; Schwartz S
    Infection; 2014 Apr; 42(2):429-32. PubMed ID: 24217961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
    Gebremariam T; Alkhazraji S; Baldin C; Kovanda L; Wiederhold NP; Ibrahim AS
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyphae of
    Samdavid Thanapaul RJR; Roberds A; Rios KE; Walsh TJ; Bobrov AG
    J Fungi (Basel); 2023 Sep; 9(10):. PubMed ID: 37888214
    [No Abstract]   [Full Text] [Related]  

  • 32.
    Szebenyi C; Gu Y; Gebremariam T; Kocsubé S; Kiss-Vetráb S; Jáger O; Patai R; Spisák K; Sinka R; Binder U; Homa M; Vágvölgyi C; Ibrahim AS; Nagy G; Papp T
    mBio; 2023 Feb; 14(1):e0338622. PubMed ID: 36625576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran.
    Vaezi A; Walther G; Kurzai O; Mahdi D; Dadashzadeh M; Nasri E; Diba K; Badali H; Fakhim H
    Mycoses; 2021 Jul; 64(7):780-787. PubMed ID: 33835599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
    Spreghini E; Orlando F; Giannini D; Barchiesi F
    J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.
    Antoniadi K; Iosifidis E; Vasileiou E; Tsipou C; Lialias I; Papakonstantinou E; Kattamis A; Polychronopoulou S; Roilides E; Tragiannidis A
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):176-179. PubMed ID: 32890077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibility.
    Kaerger K; Schwartze VU; Dolatabadi S; Nyilasi I; Kovács SA; Binder U; Papp T; Hoog Sd; Jacobsen ID; Voigt K
    Virulence; 2015; 6(4):395-403. PubMed ID: 26065324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
    Ledoux MP; Denis J; Nivoix Y; Herbrecht R
    J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model.
    Takemoto K; Yamamoto Y; Kanazawa K
    J Infect Chemother; 2010 Dec; 16(6):388-95. PubMed ID: 20535522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
    Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
    Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
    Wilby KJ
    Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):281-290. PubMed ID: 29101732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.